In Push Towards Electric Cars, Batteries and Fuel Cells Both in the Mix
Cornell University
The Department of Architecture at Cal Poly Pomona will honor Guy Nordenson with the Richard Neutra Award for Professional Excellence.
“People have always been after the silver bullet against cancer and there are few things that are as relevant across cancer types as p53. Now the question is what is the best approach to harness it,” says senior author Joaquin Espinosa, PhD.
Researchers at University of California San Diego School of Medicine, with national collaborators, have identified a series of molecular clues to understanding the formation of cerebral cavernous malformations (CCMs). The study offers the first genome-wide analysis of the transcriptome of brain microvascular endothelial cells after KRIT1 inactivation.
A team of computer scientists has won a $10.7 million grant from the Office of the Director of National Intelligence to create an information retrieval and translation system for languages that are not widely used.
Genome-wide rice studies yield first major, large-scale collection of mutations for grass model crops, vital to boosting biofuel production.
Researchers at Johns Hopkins Applied Physics Laboratory have demonstrated a significant advancement in the preservation of certain kinds of therapeutics in a portable, stable, and heat resistant form that is ideal for applications in remote or challenging areas.
Participating in Head Start may help prevent young children from being placed in foster care, finds a national study led by a Michigan State University researcher.
The AAN is the Who's Who of nursing leaders but the pool of CRNAs is even smaller. There are less than 100 nurse anesthetists that have been inducted as a fellow of a little over 2000 nurses.
One of the health care issues about which seemingly all Americans agree: Prescription drug prices have skyrocketed. And they keep going higher. How do Americans get better value for their health care dollars?One answer may be novel pricing models that more closely link a drug’s price to its value, rather than paying for volume.
Scientists at Albert Einstein College of Medicine have discovered the first compound that directly makes cancer cells commit suicide while sparing healthy cells. The new treatment approach, described in today’s issue of Cancer Cell, was directed against acute myeloid leukemia (AML) cells but may also have potential for attacking other types of cancers.
To accelerate innovation and adoption of new lightweighting technologies for on-highway vehicles, the Lightweight Materials National Laboratory Consortium, or LightMAT, is overseeing a second directed funding- assistance call. Interested industry partners wanting to collaborate with research experts and leverage unique materials capabilities at the U.S. Department of Energy national laboratories are encouraged to apply.
Researchers at The Wistar Institute have uncovered new aspects of the three-dimensional organization of the genome, specifically how the genetic material is compacted and de-compacted in a timely fashion during the different phases of the cell cycle.
Advancements in individualized medicine are offering health care providers new tools to quickly and accurately diagnose, treat, predict and, eventually, prevent disease.
The book, written by Eric Rasmussen, gives parents the training necessary to help kids process the negative and absorb the positive effects from all forms of media.
The Icahn School of Medicine at Mount Sinai is preparing to host the 6th annual SINAInnovations conference, whose theme this year is “Cancer.”
The WVU Foundation is organizing the University’s inaugural Day of Giving, 24-hour online fundraising effort, as a simple way for University supporters to contribute to the Foundation’s “State of Minds” Campaign
UCLA scientists have discovered a potential combination treatment for glioblastoma, the deadliest form of brain cancer in adults. The three-year study led by Dr. David Nathanson, a member of UCLA's Jonsson Comprehensive Cancer Center, found that the drug combination tested in mice disrupts and exploits glucose intake, essentially cutting off the tumor's nutrients and energy supply. This treatment then stimulates cell death pathways-which control the cancer cells' fate- and prevents the glioblastoma from getting bigger.